These findings underscore the functional significance of PTEN and CDKN2A deficiencies in conferring selective growth advantage and promoting proliferation and migration in Oncopig HCC cells, consistent with their established tumor suppressor roles in human HCC. The gene discussed is PTEN; the disease is neoplasm.